For in vitro diagnostic use. Others CKMB IVD CKMB CPS_000071 Creatine Kinase-MB 08 057 486 190 8 057 486 190 08057486190 8057486190 08057486190 CKMB, 150T, cobas c pack green CKMB 07613336121139 Reagents, kits 150 tests cobas c 303/503/703 true 07 442 050 190 7 442 050 190 07442050190 7442050190 07442050190 CK-MB 100Tests , cobas c111 CKMB 04015630940837 Reagents, kits 2 × 50 tests cobas c 111 true 05 168 562 188 5 168 562 188 05168562188 5168562188 05168562188 CKMB, 600Tests, cobas c 701 CKMB 07613336161722 Reagents, kits 600 tests cobas c 701/702 07 190 808 190 7 190 808 190 07190808190 7190808190 07190808190 CK-MB 100Tests, cobas c/Integra CKMB 04015630940820 Reagents, kits 100 tests COBAS INTEGRA 400 Plus, cobas c 303/311/501/502 true 05 168 562 214 5 168 562 214 05168562214 5168562214 05168562214 CKMB, 600Tests, cobas c 701 CKMB 07613336161739 Reagents, kits 600 tests cobas c 701/702 true 05 168 562 190 5 168 562 190 05168562190 5168562190 05168562190 CKMB, 600Tests, cobas c 701 CKMB 04015630924981 Reagents, kits 600 tests cobas c 701/702 true 08057486500 CKMB Creatine Kinase-MB en 9 FF00000006CA560E FF000000047D2E0E 08057486190 08057486214 10299 cobas c 703 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of the catalytic activity of creatine kinase MB subunit (CK‑MB) in human serum and plasma on cobas c systems. en 07531435001 CKMB Creatine Kinase-MB en 4 FF0000000670630E FF000000016C000E 07442050190 307 cobas c 111 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of the catalytic activity of creatine kinase MB subunit (CK‑MB) in human serum and plasma on the cobas c 111 system. en 07190808500 CKMB Creatine Kinase-MB en 5 FF00000006706F0E FF0000000171190E 07190808190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of the catalytic activity of creatine kinase MB subunit (CK‑MB) in human serum and plasma on cobas c and COBAS INTEGRA systems. en 0107190808190c501 CKMB Creatine Kinase-MB en 4 FF00000005BD560E FF00000001711A0E 07190808190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of the catalytic activity of creatine kinase MB subunit (CK‑MB) in human serum and plasma on cobas c systems. en 0107190808190COIN CKMB Creatine Kinase-MB en 4 FF00000005B9AC0E FF0000000170F40E 07190808190 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of the catalytic activity of creatine kinase MB subunit (CK‑MB) in human serum and plasma on COBAS INTEGRA systems. en 0105168562190c701 CKMB Creatine Kinase-MB en 9 FF00000005B8A20E FF00000005129D0E 05168562190 05168562214 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of the catalytic activity of creatine kinase MB subunit (CK‑MB) in human serum and plasma oncobas c systems. en 05168562500 CKMB Creatine Kinase-MB en 10 FF0000000670700E FF000000005EF30E 05168562190 05168562214 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of the catalytic activity of creatine kinase MB subunit (CK‑MB) in human serum and plasma on cobas c systems. en

User Profile

Select your user profile

CKMB

Overview

Detailed Specifications

Ordering Information

Compatible Instruments

Technical Documents

Access important product documentation including relevant certificates and other resources.